4 ms·

Time for these universities to pick up the tab and run a sustainable business that isn’t dependent on government handouts. If their research is high quality and

Time for these universities to pick up the tab and run a sustainable business that isn’t dependent on government handouts. If their research is high quality and valuable, it will survive. The current state of academia paper mills, unreproducible research and rampant fraud are a direct result of the spigot of money and lack of accountability.

klysm 2y ago
Complete bullshit. Research is high risk and frequently 0 return. It’s fundamentally not a sustainable business. Is it worth doing still? I would say yes. These actions by the government are fucking over people who have dedicated years of their lives to pursue advanced research degrees and academic careers.
- techright75 2y ago
  [dead]
ks2048 2y ago
They are not “running a business”. The American research Universities have been reaping great rewards for relatively small investments.
- iamleppert 2y ago
  It’s about time they start running one. The American people are done subsidizing ivory towers, meanwhile they have endowments that could fund the entirety of it themselves. Higher education is in for a rude awakening under the Trump administration. All I can say is it’s a shame Doge can’t do layoffs and clean house at some of these universities. Do away with tenure and get rid of the dead weight!
  - naijaboiler 2y ago
    This is such a stupid and myopic view. It honestly is pathetic
  - tmpz22 2y ago
    How many jobs on your resume exist solely because of the charity of American Research Universities?
johnnyanmac 2y ago
There's a good reason Acedemia and Business should be as separate as possible. Do you think we would have been researching EV's if Oil got to fund grants? Innovation isn't found by making faster horses, you can't treat tomorrows tech as you would yesterdays line budget.
adultSwim 2y ago
It's not a business, it's a public service. Basic research takes decades to bear fruit. mRNA therapies we have today wouldn't be possible without decades of subsidy. No pharma company is willing to do that long expensive research. We've seen how this model plays out. One by one, big pharma shut down its antibiotics division, precisely when we most need to antibiotics to be developed. Instead they target low cost, high reward directions, such as figuring out how to put Ozempic into a pill (instead of a shot).

klysm 2y ago

Complete bullshit. Research is high risk and frequently 0 return. It’s fundamentally not a sustainable business. Is it worth doing still? I would say yes. These actions by the government are fucking over people who have dedicated years of their lives to pursue advanced research degrees and academic careers.

techright75 2y ago
[dead]

ks2048 2y ago

They are not “running a business”. The American research Universities have been reaping great rewards for relatively small investments.

iamleppert 2y ago
It’s about time they start running one. The American people are done subsidizing ivory towers, meanwhile they have endowments that could fund the entirety of it themselves. Higher education is in for a rude awakening under the Trump administration. All I can say is it’s a shame Doge can’t do layoffs and clean house at some of these universities. Do away with tenure and get rid of the dead weight!
- naijaboiler 2y ago
  This is such a stupid and myopic view. It honestly is pathetic
- tmpz22 2y ago
  How many jobs on your resume exist solely because of the charity of American Research Universities?

johnnyanmac 2y ago

There's a good reason Acedemia and Business should be as separate as possible. Do you think we would have been researching EV's if Oil got to fund grants? Innovation isn't found by making faster horses, you can't treat tomorrows tech as you would yesterdays line budget.

adultSwim 2y ago

It's not a business, it's a public service. Basic research takes decades to bear fruit. mRNA therapies we have today wouldn't be possible without decades of subsidy. No pharma company is willing to do that long expensive research. We've seen how this model plays out. One by one, big pharma shut down its antibiotics division, precisely when we most need to antibiotics to be developed. Instead they target low cost, high reward directions, such as figuring out how to put Ozempic into a pill (instead of a shot).